文献速递腹部技术与安全MR

简化与完整MRI方案评估结直肠癌肝转移治疗反应的比较

Comparison of abbreviated and complete MRI protocols for treatment response assessment of colorectal liver metastases.
PubMed 文献 · Eur Radiol · 2024-12-10

本研究回顾性纳入2012年1月1日至2021年12月3日接受化疗且至少有一次钆塞酸增强MRI随访的结直肠癌肝转移连续患者,比较简化MRI与完整MRI评估治疗反应。7名放射科医生评估RECIST 1.1分类及新病灶,简化MRI与完整MRI的阅者内一致性为中等至相当(κ 0.63–0.89),阅者间一致性RECIST 1.1分类为相当(κ 0.71 vs 0.68),新病灶为中等(κ 0.56 vs 0.49)。作者认为简化MRI可能作为完整MRI的替代用于随访。

要点

  • 简化MRI与完整MRI评估RECIST 1.1分类的阅者内一致性为相当(κ 0.66–0.89)。
  • 简化MRI检测新病灶的阅者内一致性为相当(κ 0.63–0.81)。
  • 简化MRI评估RECIST 1.1分类的阅者间一致性为相当(κ 0.71),新病灶为中等(κ 0.56)。

核心结论

  • 简化MRI可能作为完整MRI的替代用于结直肠癌肝转移患者的随访。

研究设计与样本

  • 回顾性研究纳入195例结直肠癌肝转移患者(平均年龄54.4±12.1岁,135例男性),每例随机选取基线和随访钆塞酸增强MRI各一次,随访MRI分为完整MRI和简化MRI两组图像;7名放射科医生间隔一个月先后评估两组图像,每名阅者分配80–91例患者,以Fleiss κ评估阅者间一致性。

诊断标准与关键数值

  • 简化MRI与完整MRI的阅者内一致性:RECIST 1.1分类κ 0.66–0.89,新病灶检出κ 0.63–0.81;阅者间一致性:简化MRI评估RECIST 1.1分类κ 0.71(95%CI 0.65–0.78),完整MRI κ 0.68(95%CI 0.61–0.75);简化MRI评估新病灶κ 0.56(95%CI 0.41–0.69),完整MRI κ 0.49(95%CI 0.35–0.65)。

临床应用与阅片要点

  • 简化MRI序列包括冠状位和轴位肝胆期成像、轴位扩散加权成像和冠状位T2加权成像;在随访评估治疗反应时,简化MRI的RECIST 1.1分类和新病灶检出与完整MRI的一致性分别为相当和中等。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare abbreviated magnetic resonance imaging (MRI) to complete MRI for treatment response assessment of colorectal liver metastases.

MATERIAL AND METHODS: This retrospective study included consecutive patients with colorectal liver metastases between January 1, 2012, and December 3, 2021, who were undergoing chemotherapy and who had at least one follow-up gadoxetic-enhanced MRI. For each patient, two MRIs (baseline MRI and follow-up MRI) were randomly selected. Follow-up MRIs were separated into two sets of images: complete MRIs, including all imaging sequences, and abbreviated MRIs, including coronal and axial hepatobiliary phase imaging, axial diffusion-weighted imaging, and coronal T2-weighted imaging. Seven radiologists reviewed the two sets of images, with a month's break in between, assessing Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 category and the presence of new lesions, with each reader assigned 80-91 patients. Inter-reader agreement was assessed using Fleiss' kappa (κ).

RESULTS: One-hundred ninety-five patients (mean age 54.4 +/- 12.1 years, 135 men) were evaluated. Intra-reader agreement between abbreviated and complete MRI was substantial for the RECIST 1.1 category (κ, 0.66-0.89) and the detection of new lesions (κ, 0.63-0.81). Inter-reader agreement was substantial for RECIST 1.1 category using abbreviated MRI and complete MRI (κ, 0.71 (95% CI: 0.65-0.78) and 0.68 (95% CI: 0.61-0.75)), and moderate for the presence of new lesions using abbreviated MRI and complete MRI (κ, 0.56 (95% CI: 0.41-0.69) and 0.49 (95% CI: 0.35-0.65)).

CONCLUSION: Abbreviated MRI may serve as an alternative to complete MRI for the follow-up of patients with colorectal liver metastases.

KEY POINTS: Question Abbreviated MRI is a time-saving and cost-effective exam, but only one study has compared it with complete MRI for treatment response assessment of colorectal liver metastases. Findings In our study, abbreviated follow-up MRI achieved substantial inter-reader agreement for the RECIST 1.1 category and moderate inter-reader agreement for the presence of new lesions. Clinical relevance Abbreviated liver MRIs are adequate substitutes for complete liver MRIs for colorectal liver metastases in the follow-up setting when the goal is to assess treatment response, resulting in shorter examination times and potential reductions in costs.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. El Homsi M, Bou Ayache J, Fernandes MC, et al. Comparison of abbreviated and complete MRI protocols for treatment response assessment of colorectal liver metastases. Eur Radiol. 2024. PMID: 39658684. doi:10.1007/s00330-024-11277-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。